Shaving critical minutes off the time it takes to diagnose a heart attack and begin treatment could be as simple as the push of a button....
Biotherapeutics specialist Geneos Therapeutics has clinched US$17m in second-round funding to help its development of tumour neoantigen targeted personalised immunotherapies for liver cancer patients. Led by...
An AI-enabled tool that can predict when heart attacks will strike has been devised by researchers at Cedars-Sinai Medical Center, Los Angeles. In tests, the tool...
The life sciences sector’s failure to adequately provide ‘connected health’ products and services to patients will prove a boon to Big Tech, according to a new...
Neuroscience research has received a bounty over the past decade thanks to multidisciplinary collaboration and the dividends of digitalisation, say leading scientists in the field. Fifteen...
Live-cell assay systems specialist Axion BioSystems of Atlanta, Georgia has purchased Netherlands-based CytoSMART Technologies for its kinetic live-cell imaging analysis. Terms were not disclosed. The acquisition...
HT World reports on the possibilities of continuous viral evolution, in conversation with Dr Benjamin Bartelle of Arizona State University.
